AstraZeneca, ZEGFROVY, Sunvozertinib, EGFR Exon 20 Insertion, Non-Small Cell Lung Cancer, NSCLC, Lung Cancer, Targeted Therapy, Oncology, WU-KONG1B, WU-KONG28,

CAMBRIDGE, U.K. — October 22, 2026 AstraZeneca announced the U.S. availability of ZEGFROVY® (sunvozertinib) for adults with locally advanced...